Press release
Peptide Based Metabolic Disorders Therapeutics Market Analysis and Value Forecast Snapshot by End-use Industry 2018-2020
Peptide Based Metabolic Disorders Therapeutics
There are several ongoing research activities and technological developments in accordance with medical research activities which focus on treatment of various ailments. Peptide therapeutics are used to treat several of these ailments, of which metabolic disorders are one type. Peptides possess good stability, efficacy, safety, and moreover, they are small in size, and hence can be easily synchronized. These advantages fuel the growth of the global peptide based metabolic disorders therapeutics market. To support the growth, factors such as technological advancements and increased funding in healthcare, and the impressive business growth of biotech and pharmaceutical companies, have spurred the adoption of the peptides used to treat metabolic disorders. Such disorders have risen, and this has called for a rapid development of therapies based on peptides to treat such disorders. North America is anticipated to show higher attractiveness in the global peptide based metabolic disorders therapeutics market.
Request Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=187
North America Domination in the Peptide Based Metabolic Disorders Therapeutics
With respect to the global peptide based metabolic disorders therapeutics market, according to the market observation in 2016 and 2017, the region of North America is expected to dominate the global market in terms of higher market share. In terms of revenues, North America is poised to grow at a higher growth rate, registering a CAGR of 10.6% throughout the period of forecast of 2017 to 2022. This region is expected to show the highest market attractiveness index, and is the most lucrative region for the growth of the global peptide based metabolic disorders therapeutics market. Middle East and Africa (MEA) and Latin America regions will show slower growth rate as compared to North America, as well as a comparatively low market revenue share
APEJ Shows a Similar Growth Rate
The Asia-Pacific excluding Japan (APEJ) region had shown rapid growth in the past with respect to global peptide based metabolic disorders therapeutics market, and is poised to reflect a higher growth rate, as fast as North America. APEJ will register a CAGR of 10.5% during the forecast period. The main reasons for this kind of growth is the strict government regulations for the upcoming players, higher number of pharmaceutical companies, increased foreign direct investment and development of technologies. Moreover, the government encourages to increase the investment in the healthcare industry to discover and invent new methods & technologies to better the health of the patients and enhance treatment outcomes. Europe region, following APEJ region, also reflects itself as a positive platform for the growth of the global peptide based metabolic disorders therapeutics market.
Request/View Toc@ https://www.factmr.com/connectus/sample?flag=T&rep_id=187
Competition Tracking
The report also profiles companies that are expected to remain active in the expansion of the global peptide based metabolic disorders therapeutics market through 2022, which include AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., PolyPeptide Group, Novo Nordisk A/S, Merck & Co., Inc., Ipsen S.A, Eli Lilly and Company, CordenPharma International, and Bachem Holding AG.
Liraglutide Dominates the Drug Class Category
The liraglutide segment by drug class reflects a higher market share by revenue and dominates the global market by drug class. The market share of this segment is more than two and a half times than that of the exenatide segment as of 2017. However, it is anticipated that this segment will lose BPS by the end of 2022. The growth of liraglutide segment is slow as compared to the growth rates of the exenatide and others segments throughout the period of forecast.
Exenatide and Others Segments Have a Tie
The exenatide and others segments by drug class show similar growth rate and hence can be said to congruently move along during the period of forecast. However, the exenatide segment enjoys a higher market share than the others segment, more than three times than that of the others segment during 2017 and this trend is expected to run its course throughout the period of forecast. Both these segments are expected to show a gain in the BPS by the end of 2022.
Speak To Research Analyst for Detailed Insights @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=187
Detailed TOC of Global Peptide Based Metabolic Disorders Therapeutics Market by Manufacturers, Regions, Type and Application, Forecast to 2022
1. Global Peptide Based Metabolic Disorders Therapeutics Market - Executive Summary
2. Global Peptide Based Metabolic Disorders Therapeutics Market Overview
2.1. Introduction
2.1.1. Global Peptide Based Metabolic Disorders Therapeutics Market Taxonomy
2.1.2. Global Peptide Based Metabolic Disorders Therapeutics Market Definition
2.2. Global Peptide Based Metabolic Disorders Therapeutics Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global Peptide Based Metabolic Disorders Therapeutics Market Y-o-Y Growth
2.3. Global Peptide Based Metabolic Disorders Therapeutics Market Dynamics
2.4. Regulations
2.5. Supply Chain
2.6. Cost Structure
2.7. Average Pricing Analysis
2.8. Epidemiology
2.9. Key Participants Market Presence (Intensity Map) By Region
Access This Report @ https://www.factmr.com/checkout/187/S
3. Global Peptide Based Metabolic Disorders Therapeutics Market Analysis and Forecast By Drug
3.1. Global Peptide Based Metabolic Disorders Therapeutics Market Size and Forecast By Drug, 2012-2022
3.1.1. Liraglutide Peptide Based Metabolic Disorders Therapeutics Market Size and Forecast, 2012-2022
3.1.1.1. Revenue (US$ Mn) Comparison, By Region
3.1.1.2. Market Share Comparison, By Region
3.1.1.3. Y-o-Y growth Comparison, By Region
3.1.2. Exenatide Peptide Based Metabolic Disorders Therapeutics Market Size and Forecast, 2012-2022
3.1.2.1. Revenue (US$ Mn) Comparison, By Region
3.1.2.2. Market Share Comparison, By Region
3.1.2.3. Y-o-Y growth Comparison, By Region
3.1.3. Others Peptide Based Metabolic Disorders Therapeutics Market Size and Forecast, 2012-2022
3.1.3.1. Revenue (US$ Mn) Comparison, By Region
3.1.3.2. Market Share Comparison, By Region
3.1.3.3. Y-o-Y growth Comparison, By Region
4. Global Peptide Based Metabolic Disorders Therapeutics Market Analysis and Forecast By Distribution Channel
4.1. Global Peptide Based Metabolic Disorders Therapeutics Market Size and Forecast By Distribution Channel, 2012-2022
4.1.1. Hospital Pharmacies Peptide Based Metabolic Disorders Therapeutics Market Size and Forecast, 2012-2022
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Retail Pharmacies Peptide Based Metabolic Disorders Therapeutics Market Size and Forecast, 2012-2022
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.1.3. Online Pharmacies Peptide Based Metabolic Disorders Therapeutics Market Size and Forecast, 2012-2022
4.1.3.1. Revenue (US$ Mn) Comparison, By Region
4.1.3.2. Market Share Comparison, By Region
4.1.3.3. Y-o-Y growth Comparison, By Region
5. Global Peptide Based Metabolic Disorders Therapeutics Market Analysis and Forecast By Region
5.1. Global Peptide Based Metabolic Disorders Therapeutics Market Size and Forecast, 2012-2022
5.1.1. North America Peptide Based Metabolic Disorders Therapeutics Market Size and Forecast, 2012-2022
5.1.1.1. Revenue (US$ Mn) Comparison, By Drug
5.1.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.2. Latin America Peptide Based Metabolic Disorders Therapeutics Market Size and Forecast, 2012-2022
5.1.2.1. Revenue (US$ Mn) Comparison, By Drug
5.1.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.3. Europe Peptide Based Metabolic Disorders Therapeutics Market Size and Forecast, 2012-2022
5.1.3.1. Revenue (US$ Mn) Comparison, By Drug
5.1.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.4. Japan Peptide Based Metabolic Disorders Therapeutics Market Size and Forecast, 2012-2022
5.1.4.1. Revenue (US$ Mn) Comparison, By Drug
5.1.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.5. APEJ Peptide Based Metabolic Disorders Therapeutics Market Size and Forecast, 2012-2022
5.1.5.1. Revenue (US$ Mn) Comparison, By Drug
5.1.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.6. MEA Peptide Based Metabolic Disorders Therapeutics Market Size and Forecast, 2012-2022
5.1.6.1. Revenue (US$ Mn) Comparison, By Drug
5.1.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel
And Continue....
List of Figures, Tables and Charts Available in Global Peptide Based Metabolic Disorders Therapeutics Market 2017 by Manufacturers, Regions, Type and Application, Forecast to 2022
TABLE 1 Global Peptide Based Metabolic Disorders Therapeutics Market Value (US$ Mn), 2012-2016
TABLE 2 Global Peptide Based Metabolic Disorders Therapeutics Market Value (US$ Mn), 2017-2022
TABLE 3 Global Peptide Based Metabolic Disorders Therapeutics Market Value (US$ Mn) and Y-o-Y, 2015-2022
TABLE 4 Global Liraglutide Segment Value (US$ Mn), By Region 2012-2016
TABLE 5 Global Liraglutide Segment Value (US$ Mn), By Region 2017-2022
TABLE 6 Global Liraglutide Segment Market Share, By Region 2012-2016
TABLE 7 Global Liraglutide Segment Market Share, By Region 2017-2022
TABLE 8 Global Liraglutide Segment Y-o-Y, By Region 2015-2022
TABLE 9 Global Exenatide Segment Value (US$ Mn), By Region 2012-2016
TABLE 10 Global Exenatide Segment Value (US$ Mn), By Region 2017-2022
TABLE 11 Global Exenatide Segment Market Share, By Region 2012-2016
TABLE 12 Global Exenatide Segment Market Share, By Region 2017-2022
TABLE 13 Global Exenatide Segment Y-o-Y, By Region 2015-2022
TABLE 14 Global Others Segment Value (US$ Mn), By Region 2012-2016
TABLE 15 Global Others Segment Value (US$ Mn), By Region 2017-2022
And Continue....
FIG. 1 Global Peptide Based Metabolic Disorders Therapeutics Market Value (US$ Mn), 2012-2016
FIG. 2 Global Peptide Based Metabolic Disorders Therapeutics Market Value (US$ Mn) Forecast, 2017-2022
FIG. 3 Global Peptide Based Metabolic Disorders Therapeutics Market Value (US$ Mn) and Y-o-Y, 2015-2022
FIG. 4 Global Liraglutide Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 5 Global Liraglutide Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 6 Global Liraglutide Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 7 Global Exenatide Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 8 Global Exenatide Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 9 Global Exenatide Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 10 Global Others Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 11 Global Others Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 12 Global Others Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 13 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 14 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 15 Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015-2022
About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Follow Us on Linkedin: www.linkedin.com/company/factmr/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Based Metabolic Disorders Therapeutics Market Analysis and Value Forecast Snapshot by End-use Industry 2018-2020 here
News-ID: 1595467 • Views: …
More Releases from Fact.MR
Agricultural Film Market is forecasted to reach US$ 21 billion with 5.9% CAGR by …
Fact.MR, a market research and competitive intelligence service, states that historically, the use of Agricultural Films grew at a 3.5% CAGR from 2016 to 2020, with the United States, China, India, and Japan holding a sizable portion of the global market. by 2021, the greenhouse film industry is expected to have grown to a valuation of over US$ 10 billion, largely due to price increases in agricultural films.
For More Insights…
Medical Equipment Rental Market is projected to expand at a CAGR of 5.5% to reac …
The latest industry analysis from Fact.MR, a company that offers competitive intelligence and market research, projects that the global Medical Equipment Rental Market will grow at a 5.5% CAGR and reach US$ 98 billion in size by the end of 2033.
The industry that deals with the short-term rental or lease of medical equipment to healthcare facilities, organizations, and individuals is known as the "medical equipment rental market." The goal of…
Craft Beer Market is forecasted to reach a value of US$ 174.68 Billion by 2032
The worldwide craft beer market was expected to be worth $76.3 billion in 2020 and $81.64 billion in 2021. The market will grow at a steady CAGR of 6.9% between 2022 and 2032. By the end of 2032, this market is predicted to have a global valuation of US$174.68 billion.
The surge in demand for more beer styles coupled with increase in per capita income among the target customers has triggered…
Window Blinds Market Forecasted to Achieve US$ 4.69 Billion by 2034
The global window blinds market is expected to reach $2.99 billion in 2024, growing at a 5.8% CAGR to $4.69 billion by the end of 2034.
Window blinds are adjustable window coverings made of slats or vanes, allowing for versatile control over light and privacy. They come in various materials, including wood, metal, or plastic, and can be easily adjusted to regulate sunlight and maintain privacy. Unlike heavy curtains, blinds are…
More Releases for Region
Medical Marijuana Market - (region Name) Is The Leading Region In The Global Ind …
Zion Market Research Offers an 8-Year Forecast In 110+ Pages Research Report Titled "Medical Marijuana Market by Product (Dried Form and Extract Form), by Application (Pain Management, Seizure, and Others), and by Distribution Channel (Retail Pharmacy and E-Commerce): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 - 2024" Between Forecasting Years. The main objective of this Male Infertility Treatment Market report is to offer update and information on the market…
Pajamas Market 2025 | Market Forecast by Product, Application & Region, Cost Str …
Pajamas Market Overview
Reports Monitor has deployed a patented Pajamas Market. research methodology that is the complete concoction of meticulous primary and secondary research together with the entrust of the industry specialists. The research study and number crunching then persist a multi-layer authentication process to clean up all the required quantitative and qualitative insights that could profit business by directly striking the long-term decisions. This research methodology has been applied to examine the Pajamas market…
US Men’s Underwear Market 2026 |Industry Key Regions : Northeast, West region, …
As the large amount of data is being generated everyday by companies all over the world, a new research study titled “Men’s Underwear Market: Increasing Number of Metrosexual Men in the U.S. Anticipated to Fuel Revenue Growth of the Boxer Shorts Segment During the Forecast Period: U.S. Industry Analysis and Opportunity Assessment, 2016-2026” has been generated and recently added into the vast database of Market Research Reports Search Engine (MRRSE).…
Ice Skating Equipment Market North America region is expected to be the most luc …
About Ice skating market
Ice skating is a popular activity in several snow clad regions around the world. Ice skating equipment market is impacted by several factors which directly have relation with the growth of the market. The increasing number of people choosing ice skating either for leisure or thrill, increasing number of waterless ice skating arenas, rising eco ice skating rinks especially in the emerging economies, innovations in equipment…
Narrowband Iot Market Technology In The Region Account For The Dominance Of The …
Some of the prominent participants in the global narrowband IoT market are Huawei Technologies Co. Ltd., Ericsson Corporation, Nokia Corporation, Quectel Wireless solutions Co. Ltd., Sierra Wireless, Deutsche Telekom, China Unicom, Qualcomm Technologies Inc., Vodafone Group plc, u-blox SEQUANS Communications SA, ZTE Corporation, Intel Corporation, China Telekom, and Etisalat Corporation.
As per a report by Transparency Market Research (TMR), the global narrowband IoT market is expected to attain a value of…
Superyacht Market: Analysis By Type , By Region, By Country: Opportunities and F …
ReportsWeb.com has announced the addition of the “Global SUPERYACHTS Market Research Report 2017” The report focuses on global major leading industry players with information such as company profiles, product picture and specification.
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Superyachts Market on the basis of Type (Motor, Sailing, Open, Sport Fishing,…
